KE
Kasivit Editorial Team
Evidence-based health research
June 2026 · 10 min read
🔬 Evidence-Based
📋 What This Article Covers
Statins lower blood levels of CoQ101 because they block an early step in the pathway that also makes it.3 Whether that matters for statin muscle symptoms is less clear. This article reviews what the clinical evidence shows about CoQ10 supplementation for statin users, including trials that found no benefit.
- Why statins lower blood CoQ10 levels, and what is and is not known about muscle levels
- What the clinical trials show about CoQ10 for statin-induced muscle pain
- What is known about CoQ10 and heart health, beyond the statin question
- Ubiquinone vs. ubiquinol: what is and is not known
- What is known about dosing and timing, safety cautions, and what not to expect
Approximately 92 million Americans have high cholesterol, and roughly 35 million take a statin medication to manage it. Atorvastatin (Lipitor), rosuvastatin (Crestor), and simvastatin (Zocor) are collectively among the most prescribed drugs in the United States. Their cardiovascular benefit — reduced risk of heart attack, stroke, and cardiovascular mortality — is among the most robustly documented in all of medicine.
What is far less discussed is a metabolic consequence that follows from how statins work: lower blood levels of coenzyme Q10 (CoQ10), a molecule that every cell in your body depends on for energy production. This is a documented pharmacological effect.1 Whether it explains muscle pain, one of the most common reasons people stop taking their statin, is a separate question that has not been established.3
This article reviews what the evidence actually shows — the mechanistic research, the clinical trials, and the honest limits of what we know — so that statin users can make an informed decision about CoQ10 supplementation.
Background
What Is CoQ10 — and Why Does It Matter?
Coenzyme Q10 (ubiquinone) is a fat-soluble compound found in virtually every cell of the body. It functions in two essential roles: as a critical component of the mitochondrial electron transport chain (the machinery that produces ATP, your cells' primary energy currency), and as a potent antioxidant protecting cell membranes from oxidative damage.
CoQ10 is produced endogenously — your body synthesizes it — but production declines with age. Levels begin falling meaningfully after age 40, reaching particularly low concentrations in the heart, liver, and skeletal muscle by the sixth decade of life. These happen to be the tissues with the highest energy demands and the greatest sensitivity to CoQ10 insufficiency.
−0.44 µmol/L
Average fall in plasma CoQ10 across 8 placebo-controlled statin treatment arms in a meta-analysis. Whether muscle CoQ10 falls is less clear: one trial found a fall with simvastatin 80 mg/day but not with atorvastatin 40 mg/day.2
Banach M et al. Pharmacol Res 2015;99:329–361
🔬 The Mechanism — Why Statins Deplete CoQ10
The Same Pathway, the Same Enzyme
Statins work by inhibiting HMG-CoA reductase — the rate-limiting enzyme in the mevalonate pathway. This pathway produces cholesterol. It also produces CoQ10, dolichols, and other isoprenoid compounds that the body depends on for cellular function.
When statins block the mevalonate pathway upstream, cholesterol production falls — and so does CoQ10 biosynthesis. These are not two separate effects; they are the same biochemical consequence of blocking the same enzyme. This is why the fall in blood CoQ10 is a direct, predictable pharmacological outcome of statin therapy,1 although its clinical significance is not clear.3
In a meta-analysis of placebo-controlled trials, plasma CoQ10 fell with all four statins studied (atorvastatin, simvastatin, rosuvastatin and pravastatin), with no clear difference between lipophilic and hydrophilic statins.1 Plasma levels are a poor proxy for muscle levels, and a review found insufficient evidence from human studies that statins cause pathologically low tissue CoQ10.3 In one randomized trial, muscle CoQ10 fell with simvastatin 80 mg/day but not with atorvastatin 40 mg/day.2
One proposed explanation for statin muscle symptoms is reduced CoQ10 in muscle cells, which would limit energy production under physical load. This has not been established: a biopsy study of 18 people with statin-related myopathy found muscle CoQ10 was not statistically different from controls,4 and a review found insufficient evidence linking statins to pathologically low tissue CoQ10.3 In a series of blinded n-of-1 trials in 200 people who had stopped or were considering stopping a statin because of muscle symptoms, symptom scores on atorvastatin 20 mg and on placebo did not differ on average, and two-thirds of those completing the trial reported restarting a statin.5
Clinical Evidence
CoQ10 for Statin-Induced Muscle Pain: What the Trials Show
The question of whether CoQ10 supplementation reduces statin myopathy is one of the more contested areas in integrative cardiology. The evidence is mixed: some small trials report less muscle pain with CoQ10, while a randomized trial and several meta-analyses found no significant benefit. Here is a reading of what the main studies found.
📊
Meta-analysis of 6 RCTs: no significant overall effect of CoQ10 on statin muscle pain
Banach and colleagues pooled six randomized trials (302 patients taking statins). CoQ10 had no significant effect on muscle pain (a trend toward less pain did not reach statistical significance) or on plasma creatine kinase, and the authors concluded that the results do not suggest any significant benefit and that larger, well-designed trials are needed.6 Later meta-analyses disagree with one another: two found no benefit for muscle pain7,8 and two found a reduction.9,10
Key finding: Results are mixed. Some small trials report less muscle pain with CoQ10, while others, including a randomized trial of 600 mg/day ubiquinol in people with confirmed statin muscle pain, found no benefit.11
📊
CoQ10 100 mg/day reduced statin muscle pain scores by 40% over 30 days in a small randomized trial (32 patients)
In a small randomized, double-blind trial by Caso and colleagues (32 patients), statin users with muscle symptoms received either CoQ10 (100 mg/day, n=18) or vitamin E (400 IU/day, n=14) for 30 days. Pain severity decreased by 40% and pain interference with daily activities by 38% in the CoQ10 group, with no significant change in the vitamin E group. The trial was small and used vitamin E rather than an inactive placebo as the comparison, and a later randomized trial in people with confirmed statin muscle pain found no benefit.11
Key finding: In this small trial, pain scores fell by 40% with CoQ10 100 mg/day over 30 days, versus no significant change with vitamin E.12
📊
CoQ10 50 mg twice daily reduced muscle pain scores in 50 statin users over 30 days
Skarlovnik and colleagues randomized 50 statin users with mild-to-moderate muscle pain to CoQ10 (50 mg twice daily, 100 mg/day in total) or placebo for 30 days. Pain severity and pain interference scores fell more with CoQ10 than with placebo (relative reductions of 33% and 40%).13 This was a small, short trial.
Key finding: A 2020 meta-analysis found that CoQ10 did not increase the proportion of patients who stayed on their statin.7
⚠️
Important context: Several trials found no benefit. In a randomized trial of 41 people with confirmed simvastatin-related muscle pain, 600 mg/day ubiquinol did not reduce pain.11 A 2020 meta-analysis of seven trials (321 patients) found no improvement in muscle pain and no increase in the number of people staying on their statin.7 CoQ10 is widely used for statin muscle pain despite limited and conflicting evidence.11 Talk to your prescriber before starting it. Severe muscle pain, marked weakness or dark urine while taking a statin needs prompt medical attention and should not be treated with a supplement alone; statin use has been associated with a higher risk of rhabdomyolysis, a rare but serious form of muscle breakdown.14
Beyond Myopathy
CoQ10 and Heart Health: What Has Been Studied
CoQ10 has also been studied for heart health, although the main trial was in people with heart failure rather than in statin users.
❤️
Q-SYMBIO Trial: CoQ10 300 mg/day reduced major cardiovascular events in heart failure patients over 2 years (15% vs 26%)
The Q-SYMBIO trial, a multicenter, randomized, double-blind trial, enrolled 420 patients with moderate-to-severe heart failure. Patients randomized to CoQ10 (100 mg three times daily, 300 mg/day) in addition to standard therapy had fewer major adverse cardiovascular events at 2 years (15% vs 26%; hazard ratio 0.50). Cardiovascular mortality (9% vs 16%) and all-cause mortality (10% vs 18%) were lower as secondary endpoints, while short-term (16-week) endpoints did not change significantly. The authors concluded that long-term CoQ10 treatment in chronic heart failure is safe, improves symptoms and reduces major adverse cardiovascular events.15
Key finding: This was a trial in people with heart failure who were taking standard therapy. It does not show that CoQ10 prevents heart events in people who take statins for cholesterol.
🫀
In one small trial, CoQ10 improved measures of blood-vessel function in people with fatty liver disease
A small randomized trial in 60 people with metabolic dysfunction-associated steatotic liver disease (MASLD) found that 240 mg/day CoQ10 for six months improved blood-vessel function measures, including flow-mediated dilation, compared with no improvement on placebo.16 It was not a trial in statin users, and the outcomes measured were imaging and vascular measures, not heart attacks or strokes.
Key finding: This is early evidence from a small trial in a different patient group; it does not show that CoQ10 adds to the heart protection that statins provide.
Form & Dosing
Ubiquinone vs. Ubiquinol: Which Form Should Statin Users Choose?
CoQ10 exists in two interconvertible forms: ubiquinone (the oxidized form) and ubiquinol (the reduced, active antioxidant form). Both are biologically active; the body converts between them as needed. The practical question is which supplemental form is better absorbed and more clinically effective.
Ubiquinone (Oxidized)
- The standard form in most RCTs — including the Caso, Banach, and Q-SYMBIO trials
- Well-absorbed when taken with fat-containing meals
- Generally lower cost; widely available
- Appropriate for most statin users under age 60 with normal mitochondrial function
- Kasivit CoQ10 uses this well-studied form at 200 mg
Ubiquinol (Reduced)
- Pre-reduced form — may have superior bioavailability in older adults and those with compromised mitochondrial conversion capacity
- More clinically relevant for adults over 65 or those with significant mitochondrial dysfunction
- Higher cost; limited additional benefit vs. ubiquinone in younger, healthier populations
- No head-to-head superiority established in statin myopathy trials specifically
No head-to-head superiority of either form has been shown in statin muscle-symptom trials, so the form and dose are best chosen with your prescriber or pharmacist. Doses used in these trials ranged from 100 to 600 mg/day,10 and the Taylor trial that found no benefit used ubiquinol.11 CoQ10 is fat-soluble and is usually taken with a meal that contains fat.
Myth vs. Fact
Common Misconceptions About CoQ10 and Statins
❌ Myth
"If CoQ10 were important for statin users, my doctor would have mentioned it."
✓ Fact
Statins do lower blood CoQ10 levels,1 but whether supplementation helps statin muscle symptoms is unsettled: some small trials found benefit, while larger trials and meta-analyses are mixed.6–11 Prescribers differ in how they view it, and it is reasonable to ask yours.
❌ Myth
"CoQ10 will reduce my statin's effectiveness or lower my cholesterol results."
✓ Fact
We found no study reporting that CoQ10 weakens a statin's cholesterol-lowering effect. In the Skarlovnik trial, cholesterol values did not change after 30 days of CoQ10,13 and a 2026 meta-analysis of 64 trials in people with metabolic conditions found small average improvements in LDL cholesterol (about 4 mg/dL lower).17 Ask your prescriber before combining CoQ10 with any prescription medicine.
❌ Myth
"Statin muscle pain is purely psychological — if it was real, statins would have been pulled from the market."
✓ Fact
Muscle symptoms in people taking statins are real and worth reporting to your prescriber, and rhabdomyolysis, though rare, is a recognized risk.14 In blinded n-of-1 trials, however, average symptom scores on atorvastatin 20 mg and on placebo did not differ, so symptoms are not always caused by the statin itself.5 The link between muscle symptoms and CoQ10 depletion is a hypothesis that has not been established.3,4 The net cardiovascular benefit of statins remains clear: in a meta-analysis of 66 articles, good statin adherence was associated with fewer deaths and cardiovascular events than poor adherence.18
❌ Myth
"Natural CoQ10 from food is enough to compensate for statin-induced depletion."
✓ Fact
Dietary CoQ10 (from organ meats, fatty fish, and some nuts) provides approximately 3–6 mg/day in a typical diet. Supplemental doses used in statin muscle-symptom trials ranged from 100 to 600 mg/day.10 Whether higher CoQ10 intake prevents or treats statin muscle symptoms has not been established.
Who It's For
Who Should Consider CoQ10 Supplementation?
Not every statin user needs CoQ10 supplementation, and the evidence for benefit is mixed even in people with muscle symptoms.
| Patient Profile |
Evidence for CoQ10 |
Priority |
| Statin user with muscle pain, cramping, or weakness |
Small trials show benefit; larger trials and meta-analyses are mixed6–11
|
Option to discuss with your prescriber |
| Statin user over age 60 |
We did not find a trial showing that age predicts benefit from CoQ10 for statin muscle symptoms |
Not established |
| High-dose statin (atorvastatin 40–80 mg, rosuvastatin 20–40 mg) |
We did not find a trial showing that statin dose predicts benefit; plasma CoQ10 fell with all four statins studied1
|
Not established |
| Statin user with heart failure or cardiomyopathy |
Q-SYMBIO (people with heart failure on standard therapy) found fewer major cardiovascular events with CoQ10 300 mg/day15
|
Discuss with your cardiologist |
| Asymptomatic statin user under 50 |
No muscle symptoms to treat; the trials above enrolled people with muscle pain |
Low — no symptoms to treat |
How to Take It
CoQ10 Dosing and Safety: What to Know Before You Start
Dosing Protocol
Dose
Doses used in statin muscle-symptom trials ranged from 100 to 600 mg/day.10 Caso used 100 mg/day (40% fall in pain scores), Skarlovnik used 100 mg/day as two 50 mg doses, and Taylor used 600 mg/day of ubiquinol and found no benefit. The Q-SYMBIO heart failure trial used 300 mg/day. There is no established dose for this purpose, so ask your prescriber or pharmacist.
Timing
Take with your largest fat-containing meal. CoQ10 is fat-soluble — absorption increases significantly when co-ingested with dietary fat. Splitting the dose across two meals (e.g., lunch and dinner) may improve bioavailability at higher doses.
Duration
Trials ran for 30 to 90 days.10 If you and your prescriber decide to try CoQ10, agree a review date in advance. Consistent daily use is required.
Form
Ubiquinone and ubiquinol are both sold as CoQ10. We did not find trials comparing the two forms for statin muscle symptoms, and the Taylor trial, which found no benefit, used ubiquinol.11 Ask your prescriber or pharmacist which form suits you.
Safety
CoQ10 was generally well tolerated in the trials reviewed, and nausea and other digestive complaints have been reported; in a safety review they were not clearly related to dose.19 It is not risk-free. CoQ10 may reduce the effect of warfarin (Coumadin) in some people. One case report described a weaker warfarin response that returned to normal after CoQ10 was stopped,20 although a small crossover trial of 24 people taking 100 mg/day found no change in INR or warfarin dose.21 If you take warfarin, talk to your prescriber before starting CoQ10 and have your INR checked. CoQ10 may also lower systolic blood pressure slightly (about 3 mmHg on average in a meta-analysis of 45 trials)22 and blood sugar slightly (about 10 mg/dL fasting glucose on average in a meta-analysis of 64 trials in people with metabolic conditions);17 one case report linked CoQ10 to insulin autoimmune syndrome with severe low blood sugar.23 If you take blood-pressure or diabetes medicines, or are having chemotherapy, tell your prescriber or care team before starting CoQ10; data in cancer treatment are limited (a small phase I study of six women closed early).24 We did not review data for pregnancy, breastfeeding, or kidney or liver disease, so ask your prescriber before taking CoQ10 in these situations.
From Kasivit
Kasivit CoQ10 200mg
💊 Product Spotlight · Kasivit
Kasivit CoQ10 200mg
Ubiquinone · 30 Capsules
Formulated at 200 mg. Doses tested in statin muscle-symptom trials range from 100 to 600 mg/day.10 Kasivit CoQ10 uses the ubiquinone form, the most extensively studied supplemental CoQ10, with documented bioavailability in fat-soluble delivery. Designed for statin users, those over 40 experiencing natural CoQ10 decline, and anyone seeking cardiovascular and mitochondrial support. Free from unnecessary additives. If you take a prescription medicine, check with your prescriber or pharmacist before starting CoQ10.
Shop CoQ10 200mg → $29.99
Frequently Asked Questions
CoQ10 for Statin Users: Common Questions Answered
Do statins deplete CoQ10?
Yes — this is a direct, documented pharmacological consequence of how statins work. Statins inhibit HMG-CoA reductase, the enzyme responsible for cholesterol biosynthesis. This same enzyme is an upstream step in the mevalonate pathway that produces CoQ10. Blocking it reduces both cholesterol and CoQ10 synthesis simultaneously. Studies show that statins lower plasma CoQ10: a meta-analysis of placebo-controlled trials found an average fall of 0.44 µmol/L, significant for atorvastatin, simvastatin, rosuvastatin and pravastatin.1 Whether muscle CoQ10 falls is less clear: one trial found a fall with simvastatin 80 mg/day but not atorvastatin 40 mg/day,2 a biopsy study of people with statin-related myopathy found muscle levels not statistically different from controls,4 and a review found insufficient evidence that statins cause pathologically low tissue levels.3
Does CoQ10 help with statin muscle pain?
The evidence is mixed. A 2015 meta-analysis in Mayo Clinic Proceedings (Banach et al.) found no significant benefit of CoQ10 on statin muscle pain.6 Two later meta-analyses also found none7,8 and two found a reduction in muscle pain.9,10 The Caso 2007 trial (32 patients) reported a 40% fall in pain scores with 100 mg/day,12 while a randomized trial of 600 mg/day ubiquinol found no benefit.11 If you want to try CoQ10, discuss it with your prescriber first, and report severe or worsening muscle pain promptly.
Will CoQ10 interfere with my statin or affect my cholesterol levels?
Probably not. We found no study reporting that CoQ10 weakens a statin's cholesterol-lowering effect. In the Skarlovnik trial, cholesterol values did not change after 30 days of CoQ10,13 and a 2026 meta-analysis of 64 trials in people with metabolic conditions found small average improvements in LDL cholesterol (about 4 mg/dL lower).17 CoQ10 operates on mitochondrial energy production and antioxidant pathways, not the cholesterol biosynthesis pathway that statins target. Ask your prescriber before combining it with any prescription medicine.
What is the best dose of CoQ10 for statin users?
There is no established dose for statin muscle symptoms. The doses studied range from 100 to 600 mg/day.10 Caso used 100 mg/day (40% fall in pain scores), Skarlovnik used 100 mg/day as two 50 mg doses, and Taylor used 600 mg/day of ubiquinol and found no benefit.11 For heart failure, the Q-SYMBIO trial used 300 mg/day under medical care. Ask your prescriber or pharmacist before choosing a dose, and take CoQ10 with a fat-containing meal.
What is the difference between ubiquinone and ubiquinol for statin users?
Ubiquinone is the oxidized form of CoQ10, and ubiquinol is the pre-reduced, active antioxidant form. We did not find trials comparing the two forms for statin muscle symptoms, and the Taylor trial, which found no benefit, used ubiquinol.11 Ask your prescriber or pharmacist which form, if any, suits you.
How long does it take for CoQ10 to work for statin muscle pain?
In the trials reviewed here, muscle pain was reassessed after 30 to 90 days of CoQ10, for example at 30 days in Caso 2007.10,12 If you try CoQ10, agree a review date with your prescriber rather than expecting a fixed timeline. CoQ10 is fat-soluble, so it is usually taken with a meal that contains fat.
Is CoQ10 safe to take with statins?
CoQ10 is generally well tolerated, and none of the studies reviewed here reported that it weakened a statin's effect. The main interaction to be aware of is with warfarin (Coumadin): CoQ10 is chemically similar to vitamin K, and one case report described a weaker warfarin response that returned to normal after CoQ10 was stopped,20 although a small crossover trial found no effect on INR or warfarin dose.21 If you take warfarin, discuss CoQ10 with your prescriber and have your INR monitored after starting supplementation. CoQ10 may also lower blood pressure and blood sugar slightly,17,22 so tell your prescriber if you take blood-pressure or diabetes medicines, and data are limited for people having chemotherapy.24 Nausea and other digestive complaints have been reported.19
Should I stop my statin and take CoQ10 instead?
No. Statins have one of the strongest cardiovascular outcome evidence records in all of pharmacology. For patients prescribed statins for documented cardiovascular risk, discontinuing the medication substantially increases the risk of heart attack, stroke, and cardiovascular mortality.18 CoQ10 is a complement to statin therapy — not a replacement. If muscle pain is causing you to consider stopping your statin, discuss CoQ10 supplementation with your prescribing physician first.
🔬 Evidence-Based Summary
What the Evidence Does and Does Not Show
The evidence for CoQ10 in statin users has one firm foundation and one open question. Firm: statins lower plasma CoQ10 through a direct biochemical mechanism.1 Open: whether CoQ10 supplements reduce statin muscle symptoms. Some small trials say yes, while a 2015 meta-analysis, a randomized trial of 600 mg/day ubiquinol and other analyses found no significant benefit, and later meta-analyses disagree.6–11 If you are considering CoQ10 for muscle symptoms, discuss it with your prescriber first.
CoQ10's heart-health evidence comes mainly from the Q-SYMBIO trial in people with heart failure,15 which does not show that CoQ10 prevents heart events in people who take statins for cholesterol.
The most appropriate framing: CoQ10 is not an alternative to statins, and it is not guaranteed to resolve statin-related muscle complaints. It is generally well tolerated, but it can interact with warfarin and may lower blood pressure and blood sugar slightly. Anyone taking a statin who is thinking about CoQ10 should raise it with their prescriber or pharmacist, and should not stop or change a statin without that conversation.
Medical Disclaimer: This article is written for educational purposes and reflects a review of peer-reviewed literature. It does not constitute medical advice and does not establish a clinician-patient relationship. CoQ10 is a dietary supplement and is not FDA-approved to treat, cure, or prevent any disease. If you are taking a statin medication, warfarin, or any other prescription medication, consult your prescribing physician before starting CoQ10. Do not discontinue any prescription medication based on information in this article. Individual responses to supplementation vary; the evidence reviewed represents population-level findings, not guaranteed individual outcomes.
References: (1) Banach M et al. Pharmacol Res. 2015;99:329-36.
PubMed ·
DOI (2) Päivä H et al. Clin Pharmacol Ther. 2005;78(1):60-8.
PubMed ·
DOI (3) Hargreaves IP et al. Drug Saf. 2005;28(8):659-76.
PubMed ·
DOI (4) Lamperti C et al. Arch Neurol. 2005;62(11):1709-12.
PubMed ·
DOI (5) Herrett E et al. BMJ. 2021;372:n135.
PubMed ·
DOI (6) Banach M et al. Mayo Clin Proc. 2015;90(1):24-34.
PubMed ·
DOI (7) Kennedy C et al. Atherosclerosis. 2020;299:1-8.
PubMed ·
DOI (8) Wei H et al. Ir J Med Sci. 2022;191(2):719-725.
PubMed ·
DOI (9) Qu H et al. J Am Heart Assoc. 2018;7(19):e009835.
PubMed ·
DOI (10) Kovacic S et al. J Nutr Sci. 2025;14:e72.
PubMed ·
DOI (11) Taylor BA et al. Atherosclerosis. 2015;238(2):329-35.
PubMed ·
DOI (12) Caso G et al. Am J Cardiol. 2007;99(10):1409-12.
PubMed ·
DOI (13) Skarlovnik A et al. Med Sci Monit. 2014;20:2183-8.
PubMed ·
DOI (14) Lu YW et al. Ther Adv Drug Saf. 2025;16:20420986251365746.
PubMed ·
DOI (15) Mortensen SA et al. JACC Heart Fail. 2014;2(6):641-9.
PubMed ·
DOI (16) Vrentzos E et al. Cardiovasc Diabetol. 2024;23(1):245.
PubMed ·
DOI (17) Zhang Z et al. J Diabetes Res. 2026;2026(1):e5587445.
PubMed ·
DOI (18) Basios A et al. J Diabetes Complications. 2025;39(8):109040.
PubMed ·
DOI (19) Hathcock JN et al. Regul Toxicol Pharmacol. 2006;45(3):282-8.
PubMed ·
DOI (20) Landbo C et al. Ugeskr Laeger. 1998;160(22):3226-7.
PubMed (21) Engelsen J, et al. Ugeskr Laeger. 2003;165(18):1868-71 (Danish; the English version is Thromb Haemost. 2002;87(6):1075-6).
PubMed ·
PubMed (English) (22) Karimi M et al. Int J Cardiol Cardiovasc Risk Prev. 2025;26:200424.
PubMed ·
DOI (23) Kusano Y J Rural Med. 2019;14(1):132-137.
PubMed ·
DOI (24) Greenlee H et al. Integr Cancer Ther. 2025;24:15347354251388014.
PubMed ·
DOI
